Time trends of Cerebrospinal fluid biomarkers of neurodegeneration in idiopathic normal pressure hydrocephalus

Manuscript Number: 

20-1361R2

Author(s): 
Kaj Blennow, Astrid Bottelbergs, Sebastiaan Engelborghs, Sanna-Kaisa Herukka, Mikko Hiltunen, Luc Janssens, Antti Junkkari, Anne Maria Koivisto, Hartmuth C. Kolb, Ville Korhonen, Ville Leinonen, Heikki Lukkarinen, Darrel Pemberton, Tuomas Rauramaa, Randy Slemmon, Johannes Streffer, Ina Tesseur, Maarten Timmers, Luc Van Nueten, Henrik Zetterberg, Peter van der Ark

Disclosures

Kaj Blennow

  • Consulting Fees:
    KB has served as a consultant, at advisory boards, or at data monitoring committees for Abcam, Axon, Biogen, JOMDD/Shimadzu. Julius Clinical, Lilly, MagQu, Novartis, Roche Diagnostics, and Siemens Healthineers
    Patents/Royalties
    co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program.

Astrid Bottelbergs

  • Nothing to Disclose

Sebastiaan Engelborghs

  • Consulting Fees:
    Consulting fees / advisory boards: Biogen, Danone, Eisiai, Novartis, Nutricia, Roche
    Grants
    • Agency: 
      Janssen Pharmaceutica and ADx Neurosciences
      Dates: 
      2015-2022

Sanna-Kaisa Herukka

  • Nothing to Disclose

Mikko Hiltunen

  • Nothing to Disclose

Luc Janssens

  • Sponsors:
    Senior Director of Janssen R&D, A Division of Janssen Pharmaceutica NV

Antti Junkkari

  • Nothing to Disclose

Anne Maria Koivisto

  • Nothing to Disclose

Hartmuth C. Kolb

  • Equity:
    Johnson & Johnson (employee stock awards)
    Sponsors:
    Johnson & Johnson (Janssen)
    Patents/Royalties
    I have patents from my research work as employee at Siemens, Lilly, Janssen. I do not receive any royalties etc from these patents.

Ville Korhonen

  • Nothing to Disclose

Ville Leinonen

  • Grants
    • Agency: 
      Janssen R&D
      Dates: 
      01-01-2014

Heikki Lukkarinen

  • Nothing to Disclose

Darrel Pemberton

  • Equity:
    Owner of Johnson and Johnson stock
    Sponsors:
    Senior Director: Neuroscience

Tuomas Rauramaa

  • Nothing to Disclose

Randy Slemmon

  • Equity:
    Own shares of Johnson and Johnson
    Sponsors:
    Janssen R&D

Johannes Streffer

  • Sponsors:
    Johannes Streffer has been full time employee by Janssen Pharmaceutica at the time of the study

Ina Tesseur

  • Equity:
    stock options of UCB Biopharma, SRL

Maarten Timmers

  • Equity:
    Johnson & Johnson
    Sponsors:
    Employment by Janssen Research & Development, a division of Janssen Pharmaceutica N.V., Beerse, Belgium

Peter van der Ark

  • Equity:
    owner J&J shares as part of yearly compensation.
    Sponsors:
    employee of Janssen R&D, Beerse, Belgium

Henrik Zetterberg

  • Consulting Fees:
    HZ has served at scientific advisory boards for Eisai, Denali, Roche Diagnostics, Wave, Samumed, Siemens Healthineers, Pinteon Therapeutics, Nervgen, AZTherapies and CogRx.
    Equity:
    HZ is one of the founders of Brain Biomarker Solutions in Gothenburg AB.
    Lecture Fees:
    HZ has given lectures in symposia sponsored by Fujirebio, Biogen, Alzecure and Cellectricon.

Luc Van Nueten

  • Disclosure not yet completed